| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 35.978 | 38.626 | 42.546 | 49.514 | 72.644 | 83.405 | 84.442 | 87.563 | 107.858 | 126.820 |
| Total Income - EUR | 35.978 | 38.626 | 42.546 | 49.514 | 72.644 | 83.620 | 84.442 | 87.564 | 107.859 | 126.821 |
| Total Expenses - EUR | 19.724 | 23.309 | 27.951 | 42.762 | 54.147 | 63.266 | 80.699 | 83.696 | 83.813 | 112.527 |
| Gross Profit/Loss - EUR | 16.254 | 15.317 | 14.595 | 6.753 | 18.498 | 20.354 | 3.743 | 3.869 | 24.046 | 14.294 |
| Net Profit/Loss - EUR | 15.174 | 14.931 | 13.403 | 6.257 | 17.771 | 19.540 | 3.000 | 3.122 | 22.990 | 10.566 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Barbu Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 13.636 | 9.614 | 17.018 | 10.344 | 4.801 | 957 | 0 |
| Current Assets | 60.067 | 26.594 | 23.385 | 43.287 | 43.899 | 40.415 | 28.771 | 58.614 | 64.858 | 49.868 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 59.924 | 25.910 | 23.022 | 42.728 | 42.435 | 36.204 | 26.427 | 55.903 | 61.669 | 46.935 |
| Cash | 143 | 684 | 362 | 559 | 1.464 | 4.212 | 2.344 | 2.711 | 3.189 | 2.933 |
| Shareholders Funds | 46.076 | 14.986 | 13.468 | 19.478 | 23.970 | 19.601 | 9.123 | 12.273 | 23.050 | 10.626 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 13.991 | 11.609 | 9.916 | 37.595 | 29.543 | 37.832 | 29.992 | 51.142 | 42.765 | 39.242 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Barbu Med Srl